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Plasma Membrane Receptors 
T he term receptor i s o ften used in the field of medi ca. I. and cell bIOlogIc 111veS tI gatlons. A good def111iti on of this word is therefore required. T he receptor should have va rious characteristi cs : specific binding of a lig-and (ligand-receptor interac ti on) ; induction of an ef-
fec t s ubsequent to the li ga nd-receptor interaction and a feedback 
regula tion on receptor activity. 
LIG AND-HECEPTO H INTEHACTIO N 
T he ligand-receptor interaction is furth er characterized as follows: 
(1) presence of a recognition site; (2) high-affinity binding; (3) 
sa tura bility and (4) reversibility of the binding; (5) displacement 
of the binding by structurall y related molecules. The latter phe-
nom e non implies that various " ligands" which differ only slightly 
in their molecular structure may have a high affinity for the sa me 
receptor. This principle is used in pharm acotherapy for the pro-
ductio n of dru gs the molecular structure of which resembles that 
of the ligand and can therefore bind in a specifi c way to the same 
receptor molecule and exert their effect. N o t onl y differences in 
the ligand but also a slight alteration of the receptor molecules 
can modulate the affinity in liga nd-receptor binding. The ligand-
receptor interaction is usually characterized by calculation of the 
affinity and number of binding sites from the scatchard plo ts. In 
vitro studies have demonstrated that the affinity as well as the 
number o f plas ma membrane receptors can be modulated by 
tempe rature [1J . This phenomenon might be ex plained by the 
fac t that the lateral fl ow of membrane material is modulated by 
tempe rature, and , as a result , the expression and/or binding of 
the plasma membrane receptor complexes are altered. It has also 
been shown that unrelated molecules on the plasma membrane 
[maj o r histocompatibility con'lplex (Ml-lC) class I molecules] may 
playa role as a structural part in va rious plas ma membrane re-
cepto rs [e . g. , epidermal gro wth facto r (EG F) , insulin , endor-
phine] [2-4] . This phenomenon, call ed compound membrane re-
cep tors, m ay also be important in various immunologic fun ctions. 
Deta il ed studies on the T-cell receptor ha ve shown that this re-
cepto r requires o ther pl as ma membrane determinants to have a 
specific binding to a li ga nd (antigen). In such a way these mem-
bran e determinants can restri ct the binding , e. g., recognition of 
the antigen by the receptor. It was shown that T 4-positive T cells 
can re cognize antigens through their T-cell receptors only in com-
bina ti on with MHC class " molecules, while TS-positive T cells 
recognize anti gens res tri cted by MI-lC cl ass I molecules [5 ,61. 
Recent studi es suggest that high-affinity T-cell receptors might 
no t re quire these accessory molecules (T 4/TS) to interact with 
ta rget cells [7]. Considerin g the induction o f a T -cell res ponse by 
(a Uo ) antigens the above-mentioned restrictions play a role . 
Because no induction of helper T cells may be induced by 
cultured keratinocytes w ith out cl ass II antigens, an allograft of 
these cultured cells ma y be tolerated [S]. 
T h e molecular structure o f the T-cell recepto r consists of 2 
disulfide-linked polypeptides termed Q' and {3, 'associated with the 
T3 co mplex present on the plas ma membrane [9, 10]. Both T3 
and the a and {3 chains are needed fo r a functional T -cell receptor 
[9, 10]. In ho mology wi th immunoglobulins the chains of the T-
cell receptor have variable and constant domains [11] . The va riable 
do m ain determines the antigen specifi city. 
EDITO RI ALS 
SPECIFIC EFFECT 
The ligand-receptor interaction on the cellular metabolism can 
result in both a nonchara cteristic and a specific effec t. A grea t 
di versity of ligand-recepto r interactions induce the sa me non-
characteristic effect (e.g., stimulation of adenylate cyclase, and /or 
protein kinase) [1 2,13]. Various in vitro model systems have also 
shown that specifi c effects are induced by the ligand-receptor 
interactions; however, the exact mode of acti on often remains 
obscure. An important question is whether the ligand-receptor 
interac ti ons, as described in vitro, also induce a specifi c effect in 
vivo. More kn owledge about the molecular-biologic background 
of the specific effects induced by the binding of the ligand to the 
receptors will enable us to determine w hether a receptor is active 
in certain cell types and tissues in vivo . 
FEEDBA C K 
In mos t recepto r studies it has been shown that binding of a ligand 
to a receptor also exerts a nega tive feedback on the ac ti vity of 
these recepto rs [14]. T his negati ve feedback regul ation can be 
installed after a specifIc effect has been induced. However, re-
versible inactiva tion of cell surface receptors can also occur after 
pro longed li gand binding. T he ligand binding to a receptor ca n 
alter the conformation of the receptors in the neighborhood , and 
as a consequence no binding or no acti va tion of these receptors 
can take place lI 5, 16]. A similar effect has been described fo r 
regul ation o f unrelated receptors [1 7]. 
After describing these characteristics of (plasma membrane) 
receptors, the distribution, molecular structure, and the relevance 
of these ligand-recepto r interactions will be discussed . 
D ISTRIBU T IO N 
For visualiza tion of ligand-receptor interactions two methods have 
been used: (1 ) a marker is attached to the ligand; (2) the ligand 
or receptor is visualized by an antibody which is attached to a 
marker l1 S]. Light microscopic studies demonstrated that va rious 
li ga nd-receptor complexes were dis tributed in a linear arrange-
ment on the cellular surface [1 9,20]. 
Also, because of cross-linking with antibodies, certain surface 
molecules can be moved to one pole of a celI (cappin g) [21] . More 
detailed morphologic data we re obtained by electron microscopic 
in vestigations, which showed that various receptors are localized 
in specifi c regions on the plas ma membrane [22-25]. This specific 
region contains a fuzzy coat on the cytoplasma side and is te rmed 
coa ted pit. T his coat contains the protein clathrin that is able to 
change its shape in such a way that membrane material is pinched 
off as coa ted vesicles. O ther receptors can be distributed at ran-
dom or in un coated regions of the plasma membrane l26,27]. 
T he internaliza tion process ofligand-recepto r molecules uses pre-
dominantl y the coated pit vesicle system , but other path ways of 
intern aliza tion are also fo und [27,2S]. M oreover, when receptor-
medi ated endocytosis occurs, the receptors can be dissociated 
from the ligand in the compartment un coupling of receptor lig-
and , and subsequently the un coupled receptor is recirculated to 
the plasma membrane [29]. By this mechanism the receptor mol-
ecule is reused fo r endocytosis. T he phenomenon of recep to r 
recycling may ah o take place, spontaneously in the absence of 
the liga nd [30]. T his means that even without a li ga nd-receptor 
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binding a m ass ive process o f internali zat ion , redistribution, and 
recyclin g of pbsma m em brane mater ial occurs. It is no tewo rth y 
that th e topology and asy mm etry of th e plasma m embrane are 
maintained. Apart from recycl in g it is possibl e th at the li gand-
receptor com plex (e .g . , EGF recepto r) is not un coupl ed but de-
li vered to the Iysoso mes /.1 8J. T he sensitivity of th e li ga nd-re-
ceptor co mplex for the acidic environm en t (p H = 5) in the first 
end oso m al ves icles is one of the facto rs determ ini ng w hether 
uncouplin g occurs o r no t 1311 . 
The process of receptor-medi ated end ocytos is ca n be of im-
portance fo r pharm acotherapy [32J. U sin g low-density li po pro-
teins (LDL) as a dru g- ca rryin g pa rticle, th ese dru gs can be deli v-
ered preferentia ll y to th ose cell s that express the LDL receptors 
[33]. In such a way a very efficien t ta rgetin g of dru gs occurs. 
MOLEC ULAR STRUCT URE 
From several m em brane receptors the molecul ar stru cture has 
been id entified [341. These receptors have o ne part sti ckin g o ut 
of the o ute rm ost laye r of th e p lasma membran e. This part has 
certain doma ins that fun ctio n as a recognition site for the li gand. 
M o noclonal recepto r antibo dies m ayor m ay not bind with th e 
sa m e domain o r epitope as recogni zed by the liga nd . T he second 
part of the plasma memb rane receptor contain s several hydro-
phobic amin o ac ids and is loca lized in the intramembrane region . 
T he third part is o ri en ted fro m th e pbsm a mem brane into th e 
cytop lasm. T hi s pa rt m ay p laya role in the movem ent of th e 
receptor and in transm ission of the recepto r's sig nal. M odifyin g 
the cytop las mic side of the EGF recepto r, it was shown th at this 
part of the membra ne receptor is needed for intern alization of the 
EGF receptor [35]. 
D ISEASES 
T he relevance of th e receptor m echanism is obv io us as certa in 
diseases ca n be att ributed to defects in receptor m etabolism. A 
good exa mple is found in th e large fi eld of lipoprotein m etabo-
lism, w here receptor m echani sm s playa determinin g ro le in the 
catabo li c degradat io n of vario us lipo pro tein classes 136J. T he el-
evated LDL se rum levels found in pati ents w ith fa mili al hyper-
cho lestero lemia are ca used by a defective LDL receptor metab-
o lism. In pat ients ho m ozygous for fa mili al hype rcho les tero lemi a 
the LDL receptors are absent . Furthe r studies of cultured fibro-
blasts of these ho m ozygous patients have shown th at at leas t 7 
differen t mutations ca n lead to the sa m e ph enoty pi c defect in LDL 
receptor meta bo lism 137/. Three important steps needed for a 
norma l LDL receptor fun ction could be del ineated: (1) synth esis 
of recepto r precursor, (2) process in g of the precursor in o rd er to 
transport the precursor to the plas ma membrane, and (3) clus-
tering and express ion of the receptor at the plasm a membrane. 
Whereas fa milial hypercho les te ro lemia is an exa mp le of a genet-
ica ll y determ in ed lipi d disorder du e to a defective LDL receptor 
fun ctio n, the in heritable lipid diso rder hype rlipo protein emi a III 
is an example of a d isease du e to an abno rm ality of th e liga nd 
apolipoprotei n E 1381. Wh en one amin o acid of this apolipoprotein 
is changed du e to mutatio n, th e cata bo li c degradat ion of inte r-
media te-densit y lipo protein s is d iminished. Persons homozygo us 
for this m od ified apo li poprotein e E (apo E2/E2) m ay develop 
hyperlipoproteinem ia III , w hen ano th er li p id d isorder is al so in-
he rited [39 1. T herefo re, m od ifi cations o f receptors as well as li g-
ands can induce a d isease. 
DERMATO LOGI C D ISEASES 
T he plas m a m embrane receptors of endotheli al cells, fibrobla sts, 
T cells, and m elanocytes that m ay be of impo rta nce in va ri ous 
ski n d iseases wi ll no t be discussed. T he role that pl as m a mcm-
brane receptors of kerati nocytes pl ay in dermatolog ic diseases is 
sti ll ve ry specul ative . 
In tissue sections from norm al sk in EGF receptors could be 
dcmonstrated in the epiderm al cel ls [40]. T hese EGF receptors 
were predominan tl y presen t in basa l ce ll b yers and in epithelial 
ce ll s of the sweat d uct [411. 
THE J OU I~NAL OF INVESTIGATIVE DEHMATOLOGY 
U sin g cultured keratinocytes, EGF, insuli n, and in sulin g rowth 
factor I (I gF I) receptors co uld be demonstrated [42-44]. M ore-
over, it was fo und th at during th e process of te rmin al differen-
tiation, the EGF and LDL recepto r act iv ity decreased sharpl y in 
cultured kerat inocytes as well as in cultured epitheli al tumor ce LI s 
145-47]. N ot onl y the bindin g of li gand to th e recepto r, but also 
the receptor-med iated endocytos is is diminished durin g the ter-
min al differentiation in keratinocy tes and epithelial tumor cells 
[48, 49]. During receptor-mediated endocytosis a characteristic 
tubular o rganell e representin g th e first end osoma l compartment 
is encountered in epithelial ce ll s [50,51 ]. U sin g io dinated EGF, 
N anney et al [521 could demonstrate an in crea sed EGF activity 
in epidermis (Iesio nal, pe rilesional) of pso ri as is vul ga ris as com-
pared w ith no rm al sk in . The same pheno m eno n occurs for LDL 
recepto r activ ity in les iona l skin of pso ri as is vu lga ris (unpublished 
data) . It has been suggested b y N anney et al [52] that the increased 
receptor acti vity in psorias is vul ga ris is caused no t o nl y by in-
creased mitotic activi ty but also by an ab normal differentiation 
of the keratinocy tes. It can be speculated th at EGF, Ig F 1, and 
LDL all have a regulatory ro le in pro liferati on and differentiation 
of the keratin ocytes . Certain inh eritable disorders of epithelial 
differenti atio n may be del in eated in the future as a pl as m a m em-
brane receptor di sease. A speculati on on th e ro le of other receptors 
in keratinocy tes is beyond this edito ri al. 
In summ ary, plasma membrane recep tors may be a dete rminin g 
factor in the process o f differenti atio n ofkeratin ocy tes. M oreover, 
the interaction of mem brane constitu en ts of ep idermal cells (Lan g-
erh ans cel ls, keratinocy tes) with T - cell receptors can pl ay an es-
sential ro le in various skin d iseases. T he rapidl y in creas in g knowl-
edge about pla sm a membran e receptors w ill enable us to unravel 
severa l skin diseases at the molecular level and m ay prov ide new 
therapeuti c m odalities. 
Dr, M. PO II CC- Wac/sci, "lid I ,'. F. /-l . ). C I"as are acimo lllledged Jar crit ical 
rearlillg of this ""I/II/script. 
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